Asthma severity is a risk factor for acute hypersensitivity reactions to contrast agents: A large-scale cohort study

Chest

Volumn 141, Issue 5, 2012, Pages 1367-1368

  Kobayashi, Daiki ^a   Takahashi, Osamu ^a   Ueda, Takuya ^a   Arioka, Hiroko ^a   Akaishi, Yu ^a,b   Fukui, Tsuguya ^a  

^a ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; STEROID;

ACUTE DISEASE; ADULT; ASTHMA; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HIGH RISK PATIENT; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TREATMENT DURATION;

EID: 84860570137     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-3143     Document Type: Letter

References (5)

1. Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol. 1994;5(2):125-137. (Pubitemid 24977068)
2. Lang DM, Alpern MB, Visintainer PF, Smith ST. Increased risk for anaphylactoid reaction from contrast media in patients on beta-adrenergic blockers or with asthma. Ann Intern Med.1991;115(4):270-276.
3. Bettmann MA, Heeren T, Greenfield A, Goudey C. Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry. Radiology. 1997;203(3):611-620. (Pubitemid 27227402)
4. The Global Initiative For Asthma. Pocket guide for asthma man agement and prevention. GINA website. http://www.ginasthma.org/pdf/GINA-Pocket-2010a.pdf. Accessed August 16, 2011.
5. Ellis AK, Day JH. Diagnosis and management of anaphylaxis. CMAJ. 2003;169(4):307-311.